Coherus Oncology, Inc. (CHRS)
0.8301
-0.07
(-7.60%)
USD |
NASDAQ |
Oct 30, 16:00
0.8327
0.00 (0.00%)
After-Hours: 20:00
Coherus Oncology Price : 0.8301 for Oct. 30, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | 0.90 | 0.9177 | 0.8239 | 0.8301 | 2.194M |
| Oct 29, 2026 | 1.15 | 1.15 | 0.805 | 0.8984 | 6.139M |
| Oct 28, 2026 | 1.08 | 1.17 | 1.05 | 1.16 | 1.406M |
| Oct 27, 2026 | 1.03 | 1.07 | 1.01 | 1.07 | 605840.0 |
| Oct 26, 2026 | 1.01 | 1.02 | 0.98 | 1.01 | 686793.0 |
| Oct 23, 2026 | 1.03 | 1.038 | 0.9881 | 1.01 | 641451.0 |
| Oct 22, 2026 | 1.02 | 1.06 | 1.015 | 1.05 | 641949.0 |
| Oct 21, 2026 | 1.01 | 1.05 | 1.005 | 1.02 | 1.277M |
| Oct 20, 2026 | 0.96 | 1.03 | 0.955 | 1.00 | 967703.0 |
| Oct 19, 2026 | 1.00 | 1.015 | 0.9400 | 0.9587 | 1.726M |
| Oct 16, 2026 | 1.07 | 1.07 | 0.9868 | 0.99 | 938501.0 |
| Oct 15, 2026 | 1.07 | 1.09 | 1.03 | 1.07 | 1.542M |
| Oct 14, 2026 | 1.05 | 1.085 | 1.011 | 1.05 | 1.718M |
| Oct 13, 2026 | 1.06 | 1.08 | 1.00 | 1.07 | 1.342M |
| Oct 12, 2026 | 1.06 | 1.066 | 1.03 | 1.03 | 1.037M |
| Oct 09, 2026 | 1.06 | 1.12 | 1.05 | 1.07 | 1.697M |
| Oct 08, 2026 | 1.01 | 1.07 | 0.974 | 1.07 | 2.142M |
| Oct 07, 2026 | 1.02 | 1.08 | 1.01 | 1.01 | 1.234M |
| Oct 06, 2026 | 1.13 | 1.13 | 1.01 | 1.03 | 2.973M |
| Oct 05, 2026 | 1.16 | 1.16 | 1.08 | 1.12 | 2.009M |
| Oct 02, 2026 | 1.19 | 1.19 | 1.145 | 1.16 | 1.183M |
| Oct 01, 2026 | 1.20 | 1.21 | 1.145 | 1.16 | 709396.0 |
| Sep 30, 2026 | 1.18 | 1.23 | 1.155 | 1.21 | 1.580M |
| Sep 29, 2026 | 1.15 | 1.20 | 1.12 | 1.18 | 1.347M |
| Sep 28, 2026 | 1.13 | 1.15 | 1.10 | 1.14 | 1.143M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Enanta Pharmaceuticals, Inc. | 10.71 |
| ACADIA Pharmaceuticals, Inc. | 20.59 |
| Alnylam Pharmaceuticals, Inc. | 165.00 |
| Anika Therapeutics, Inc. | 20.95 |
| Savara, Inc. | 4.82 |
Price Related Metrics
| PS Ratio | 2.150 |
| Price to Book Value | 2.108 |
| Earnings Yield | -123.0% |
| Market Cap | 128.23M |